Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yueling Zhong"'
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundGram-negative bacteria is a global public health problem. Treatment options include novel beta-lactamase inhibitors.ObjectivesThe objective of this study was to collect information on the efficacy and safety of novel β-lactamase inhibitor
Externí odkaz:
https://doaj.org/article/d18b5b4ff33a4e7fb007c8c2b831d4fe
Autor:
Yueling Zhong, Hong Xu, Yi Zhong, Xuemiao Zhang, Ting Zeng, Limei Li, Gaojie Xu, Minhui Li, Jin Liu, Tai Yang
Publikováno v:
BMC Complementary and Alternative Medicine, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background NGF-TrkA is well known to play a key role in propagating and sustaining pruritogenic signals, which form the pathology of chronic pruritus. Inhibition of NGF-TrkA is a known strategy for the treatment of pruritus. In the present p
Externí odkaz:
https://doaj.org/article/2da97715474340969415209dd6337e3b
Autor:
Gaojie Xu, Renghan Dong, Jin Liu, Li Zhao, Yan Zeng, Xiaofan Xiao, Jinglin An, Sheng Huang, Yueling Zhong, Bing Guang, Tai Yang
Publikováno v:
Asian Journal of Pharmaceutical Sciences, Vol 14, Iss 6, Pp 640-648 (2019)
Honokiol (HK) usage is greatly restricted by its poor aqueous solubility and limited oral bioavailability. We synthesized and characterized a novel phosphate prodrug of honokiol (HKP) for in vitro and in vivo use. HKP greatly enhanced the aqueous sol
Externí odkaz:
https://doaj.org/article/1f820ea4da1d4878bf091fe52bf720b3
Publikováno v:
Frontiers in Medicine; 2024, p1-10, 10p